NCT04996134
Domperidone Expanded Access Treatment Program
Domperidone Protocol - FDA Expanded Access Program
Aurora Health Care·ClinicalTrials.gov·drugAvailable
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Gastroparesis
- Drug/Device/Intervention
- Domperidone Oral Product
- Study type
- Expanded access
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Aurora Health Care
- Location
- Green Bay, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Summary
To allow the use of domperidone by patients with gastrointestinal disorders who have failed
 standard therapy.
ICD-10 classifications
Attention to gastrostomyGastrostomy statusOther gastritisGastritis, unspecifiedGastric diverticulum
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04996134
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT04996134 through Pure Global AI's free database. This phase not specified trial is sponsored by Aurora Health Care and is currently Available. The study focuses on Gastroparesis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.